AzTrials
AzTrials

Cardiovascular HealthNCT05986058

Preliminary Efficacy of a Technology-based Physical Activity Intervention for Older Korean Adults During the COVID-19 Pandemic

A study testing Golden Circle in people with Cardiovascular Health and Physical Function, run by University of Illinois at Urbana-Champaign at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study tested preliminary efficacy of a hybrid (web-based and center-based) PA intervention combining use of a smartwatch and mobile application. The 12-week hybrid PA intervention included 120 older Korean adults and was concurrently implemented in-person at the local senior center and at-home through a web-based… Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Cardiovascular Health, Physical Function
What is being tested?
Golden Circle
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteSouth Korea
Study dates
1 Sep 2020to 30 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged 60 and over
  • enrolled member at the participating senior center for at least three years
  • fluent in Korean

Who cannot join

  • younger than 60 years old
  • less than three years enrollment at the senior center
  • cannot read and speak Korean

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Mokdong Senior Welfare Center

    Seoul

Other trials in South Korea

About this study

This study tested preliminary efficacy of a hybrid (web-based and center-based) PA intervention combining use of a smartwatch and mobile application. The 12-week hybrid PA intervention included 120 older Korean adults and was concurrently implemented in-person at the local senior center and at-home through a web-based modality. Overall, increases were evident in systolic/diastolic blood pressure, total cholesterol, and high-density-lipoprotein at posttest, with decreases seen for triglyceride levels. Participants showed improvements in muscular function and cardiopulmonary endurance.

Being tested
Golden Circle
Keywords
Physical activity intervention, Older adults

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Golden CircleBehavioural

    The original Golden Circle project was deployed in response to the COVID-19 pandemic and the need to implement remote social services in South Korea. Golden Circle had the aim of building a case management model using a healthcare-oriented automation system based on wearable devices (smartwatches and mobile applications). Through innovative system expansions, the goals were to promote healthful CVH and physical function and cultivate self-care management skills in older Korean adults.

Study groups in NCT05986058
Study groupRoleWhat they receive
Hybrid PA interventionExperimentalThe PA intervention implemented 1-hour sessions for 12 weeks focusing on improving (1) body muscle, (2) body flexibility, (3) muscle endurance, and (4) body balance. The 12-week hybrid PA intervention was concurrently deployed in-person at a senior center and at-home through a web-based modality.
Receives: Behavioral: Golden Circle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiovascular health

    systolic and diastolic blood pressure, total cholesterol, high-density lipoprotein, and triglycerides

    Measured: Pre (baseline) and posttest (through study completion, 12 weeks later from the baseline)

Secondary outcomes (1)
  1. Physical function

    muscular function and cardiopulmonary endurance

    Measured: Pre (baseline) and posttest (through study completion, 12 weeks later from the baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start1 Sep 2020
  3. Primary completion31 Jan 2021
  4. Study completion30 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05986058
Sponsor's protocol ID
21916
Status last verified
Aug 2023
First submitted
14 Dec 2022
Last updated
14 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: It requires the data agreement from the director (Noh-Suk Park).

Questions about this trial

What is this clinical trial studying?

A study testing Golden Circle in people with Cardiovascular Health and Physical Function, run by University of Illinois at Urbana-Champaign at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiovascular health (time frame: Pre (baseline) and posttest (through study completion, 12 weeks later from the baseline)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in